Received Oct 31, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | X7R4Z | — |
administration of an expired dose of MENVEO one vial vaccine/vaccine (Menveo 1 vial) that we gave, that was expired; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 17-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number X7R4Z, expiry date 30-SEP-2025) for prophylaxis. On 14-OCT-2025, the patient received Menveo. On 14-OCT-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: administration of an expired dose of MENVEO one vial vaccine/vaccine (Menveo 1 vial) that we gave, that was expired). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 15-OCT-2025 The healthcare provider called asking for advice/safety concerns/re-administration of an expired dose of Menveo one vial vaccine. Vaccination date, vaccine detail and patient demographics were obtained in this call. No further information was obtained in this call. The vaccine administration facility was the same as primary reporter.